Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

669 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply to SGLT-2 inhibitors: Post-infarction interventional effects.
Paolisso P, Bergamaschi L, Gragnano F, Gallinoro E, Cesaro A, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Esposito G, Morici N, Andrea OJ, Casella G, Mauro C, Vassilev D, Galie N, Santulli G, Marfella R, Calabrò P, Barbato E, Pizzi C. Paolisso P, et al. Among authors: barbato e. Pharmacol Res. 2023 Mar;189:106664. doi: 10.1016/j.phrs.2023.106664. Epub 2023 Jan 13. Pharmacol Res. 2023. PMID: 36642618 Free PMC article. No abstract available.
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors.
Scisciola L, Taktaz F, Fontanella RA, Pesapane A, Surina, Cataldo V, Ghosh P, Franzese M, Puocci A, Paolisso P, Rafaniello C, Marfella R, Rizzo MR, Barbato E, Vanderheyden M, Barbieri M. Scisciola L, et al. Among authors: barbato e. Cardiovasc Diabetol. 2023 Feb 2;22(1):24. doi: 10.1186/s12933-023-01754-2. Cardiovasc Diabetol. 2023. PMID: 36732760 Free PMC article.
Same Day Discharge Strategy by Default in a Tertiary Catheterization Laboratory in Belgium: Value Based Healthcare-Change in Practice.
Wyffels E, Beles M, Baeyens A, Croeckaert K, De Potter T, Van Camp G, Collet C, Sonck J, Vanderheyden M, Bartunek J, Barbato E, Bermpeis K, Bertolone DT, Gallinoro E, Esposito G, Schoonjans G, Staelens F, Van Laer E, De Bruyne B. Wyffels E, et al. Among authors: barbato e. Health Policy. 2023 Jun;132:104826. doi: 10.1016/j.healthpol.2023.104826. Epub 2023 Apr 17. Health Policy. 2023. PMID: 37087953
Corrigendum to ' Same Day Discharge Strategy by Default in a Tertiary Catheterization Laboratory. Value Based Healthcare-Change in Practice.' [Health Policy, Volume 132, June 2023, 104826, ISSN 0168-8510].
Wyffels E, Beles M, Baeyens A, Croeckaert K, De Potter T, Van Camp G, Collet C, Sonck J, Vanderheyden M, Bartunek J, Barbato E, Bermpeis K, Bertolone DT, Gallinoro E, Esposito G, Schoonjans G, Staelens F, Van Laer E, De Bruyne B. Wyffels E, et al. Among authors: barbato e. Health Policy. 2023 Aug;134:104829. doi: 10.1016/j.healthpol.2023.104829. Epub 2023 May 4. Health Policy. 2023. PMID: 37149401 No abstract available.
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry.
Paolisso P, Bergamaschi L, Cesaro A, Gallinoro E, Gragnano F, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Belmonte M, Esposito G, Morici N, Andrea Oreglia J, Casella G, Mauro C, Vassilev D, Galie N, Santulli G, Calabrò P, Barbato E, Marfella R, Pizzi C. Paolisso P, et al. Among authors: barbato e. Diabetes Res Clin Pract. 2023 Aug;202:110766. doi: 10.1016/j.diabres.2023.110766. Epub 2023 Jun 3. Diabetes Res Clin Pract. 2023. PMID: 37276980
Accuracy of a virtual PCI planner based on coronary CT angiography in calcific lesions.
Belmonte M, Maeng M, Collet C, Norgaard BL, Otake H, Ko B, Koo BK, Mizukami T, Updegrove A, Barbato E, De Bruyne B, Leipsic J, Taylor C, Andreini D, Sonck J. Belmonte M, et al. Among authors: barbato e. J Cardiovasc Comput Tomogr. 2023 Sep-Oct;17(5):367-369. doi: 10.1016/j.jcct.2023.06.004. Epub 2023 Jul 5. J Cardiovasc Comput Tomogr. 2023. PMID: 37419721 No abstract available.
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque.
Marfella R, Prattichizzo F, Sardu C, Paolisso P, D'Onofrio N, Scisciola L, La Grotta R, Frigé C, Ferraraccio F, Panarese I, Fanelli M, Modugno P, Calafiore AM, Melchionna M, Sasso FC, Furbatto F, D'Andrea D, Siniscalchi M, Mauro C, Cesaro A, Calabrò P, Santulli G, Balestrieri ML, Barbato E, Ceriello A, Paolisso G. Marfella R, et al. Among authors: barbato e. Atherosclerosis. 2023 Aug;378:117180. doi: 10.1016/j.atherosclerosis.2023.06.971. Epub 2023 Jun 29. Atherosclerosis. 2023. PMID: 37422356
Innovative Device-Based Strategies for Managing Acute Decompensated Heart Failure.
Bertolone DT, Paolisso P, Gallinoro E, Belmonte M, Bermpeis K, De Colle C, Esposito G, Caglioni S, Fabbricatore D, Leone A, Valeriano C, Shumkova M, Storozhenko T, Viscusi MM, Botti G, Verstreken S, Morisco C, Barbato E, Bartunek J, Vanderheyden M. Bertolone DT, et al. Among authors: barbato e. Curr Probl Cardiol. 2023 Dec;48(12):102023. doi: 10.1016/j.cpcardiol.2023.102023. Epub 2023 Aug 7. Curr Probl Cardiol. 2023. PMID: 37553060 Review.
669 results